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Abstract
Echinocandins are a new generation of novel antifungal agent that inhibit cell wall b(1,3)-glucan synthesis and are normally
cidal for the human pathogen Candida albicans. Treatment of C. albicans with low levels of echinocandins stimulated chitin
synthase (CHS) gene expression, increased Chs activity, elevated chitin content and reduced efficacy of these drugs.
Elevation of chitin synthesis was mediated via the PKC, HOG, and Ca2+-calcineurin signalling pathways. Stimulation of Chs2p
and Chs8p by activators of these pathways enabled cells to survive otherwise lethal concentrations of echinocandins, even
in the absence of Chs3p and the normally essential Chs1p, which synthesize the chitinous septal ring and primary septum of
the fungus. Under such conditions, a novel proximally offset septum was synthesized that restored the capacity for cell
division, sustained the viability of the cell, and abrogated morphological and growth defects associated with echinocandin
treatment and the chs mutations. These findings anticipate potential resistance mechanisms to echinocandins. However,
echinocandins and chitin synthase inhibitors synergized strongly, highlighting the potential for combination therapies with
greatly enhanced cidal activity.
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Introduction
In fungi, two covalently cross-linked polysaccharides, b(1,3)-
glucan and chitin, form a primary scaffold that is responsible for
structural integrity and shape of the cell wall [1–4]. Other b-linked
polysaccharides and glycosylated proteins are attached to this
glucan-chitin core, thus modifying the properties of the wall. The
integrity of the cell wall scaffold must, however, be monitored and
regulated constantly to ensure cell viability. This is not a trivial
challenge since surface expansion during growth and cellular
morphogenesis requires a delicate balance to be maintained
between the rigidity and the flexibility of the cell wall. The cell wall
must be able to expand under the outwardly directed and variable
force of cell turgor, whilst maintaining sufficient rigidity to prevent
cell lysis. This balance between plasticity and rigidification must
also be achievable in the presence of extrinsic factors such as
inhibitory molecules and enzymes in the environment that may
attack the integrity of the cell wall. Responses to cell wall damage
involve a sophisticated homeostatic mechanism that is mediated
via a signalling network which communicates information about
physical stresses at the cell surface to the biosynthetic enzymes that
orchestrate cell wall synthesis and repair. The signalling pathways
and transcription factors that mediate this repair response are
termed the cell wall salvage or cell wall compensatory mechanisms
[5–8].
Echinocandins are a new class of antifungal agent, which are
non-competitive inhibitors of b(1,3)-glucan synthase [9]. Caspo-
fungin is the first echinocandin to be approved for clinical use and
is fungicidal for Candida albicans, and other Candida species, and
fungistatic for Aspergillus fumigatus [10,11]. It is active against
isolates of Candida spp. that are resistant to other antifungals such
as fluconazole [12]. Deletion of both copies of the FKS1 gene is
lethal in C. albicans, although point mutations in FKS1 can arise
that result in reduced susceptibility to caspofungin [9,13–15]. FKS1
point mutations associated with resistance accumulate in two hot
spot regions that encode residues 641–649 and 1345–1365 of
CaFks1p in C. albicans and other species [14–17]. Fungi that are
inherently less susceptible to echinocandins, have a tyrosine at
residue 641 compared to phenylalanine in that position in CaFks1p
[16,18], suggesting sequence divergence around the hot spot
regions may contribute to reduced echinocandin susceptibility.
In Saccharomyces cerevisiae deletion of ScFKS1 is not lethal and
inhibition of b(1,3)-glucan synthesis or damage to b(1,3)-glucan
results in increased levels of chitin synthesized by ScChs3p [7,19].
Scchs3D mutants are hypersensitive to caspofungin [20] and
ScCHS3 and ScFKS1 are synthetically lethal [21,22] suggesting
that Scfks1D mutants depend on chitin synthesis for their survival.
In addition microarray analyses have shown that CaCHS2
expression increases in response to caspofungin treatment
[23,24]. Treatment of S. cerevisiae [25] and Cryptococcus neoformans
[26] with caspofungin results in activation of the PKC cell integrity
pathway via phosphorylation of the mitogen activated protein
kinase, ScSlt2p/ScMkc1p. C. albicans MKC1 expression has been
found to increase in response to caspofungin treatment [27] and
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deletants in ScSLT2 are hypersensitive to caspofungin [20,25].
Damage to the cell wall involves cell wall protein sensors which
transmit signals that lead to activation of the ScRho1p GTPase,
which activates b(1,3)-glucan synthase as well as ScPkc1p and
hence the PKC cell integrity MAP kinase cascade [8]. The
downstream target of this cell wall salvage pathway is the ScRlm1p
transcription factor, which activates transcription of cell wall
related genes [28].
The Ca2+-calcineurin pathway has also been implicated in the
regulation of cell wall biosynthesis [29–31]. C. albicans calcineurin
mutants are hypersensitive to caspofungin, suggesting that the
calcineurin pathway is involved in the response to cell wall damage
caused by caspofungin [32]. Combined treatment with caspofun-
gin and the calcineurin inhibitor, cyclosporin A, prevents the
paradoxical effect of increased survival that is sometimes seen at
echinocandin concentrations well above the typical minimal
inhibitory concentration (MIC) [27]. The calcineurin inhibitors,
FK506 and cyclosporin A, have also been shown to act
synergistically with caspofungin against Aspergillus fumigatus and
Cryptococcus neoformans [26,33–35].
A primary response of fungi to cell wall damage is to up-regulate
chitin synthesis. In C. albicans there are four chitin synthase
enzymes, CaChs1p, CaChs2p, CaChs3p and CaChs8p. CaChs1p is
an essential class II enzyme that synthesizes the chitin of the
primary septum and contributes to lateral wall integrity [36];
CaChs2p and CaChs8p are two class I enzymes that account for
almost all measured chitin synthase activity in vitro [37–39] and
CaChs3p is a class IV enzyme that synthesizes the majority of cell
wall chitin, including the septal chitin ring [40]. While CaChs3p is
predominantly regulated at the post-transcriptional level, CaCHS1,
CaCHS2, and CaCHS8 can all be transcriptionally activated in
response to stimulants of the PKC, Ca2+-calcineurin and HOG
signalling pathways [31]. Here we show that pre-treatment of cells
with activators of these pathways activates CaCHS transcription
and leads to the selection of cells with increased cell wall chitin that
survive otherwise lethal concentrations of caspofungin. We also
show that activation of the cell wall compensatory pathways can
induce the synthesis of a novel salvage septum even in the absence
of CaChs3p and CaChs1p which are normally required for septum
formation and viability. Rescue of such cells was strictly dependent
on chitin synthesis from residual class I enzymes and combinations
of echinocandins and chitin synthase inhibitors exhibited synergy
in the killing of C. albicans.
Results
Echinocandins induce CHS expression via three signalling
pathways
To test whether exposure to echinocandins induced chitin
synthesis we first used a lacZ-reporter system to measure the
response of the four C. albicans CHS promoters to echinocandins at
concentrations below their MICs. Caspofungin (Figure 1) and
echinocandin B, cilofungin and anidulafungin (data not shown)
activated expression of CHS1, CHS2 and CHS8. The level of
expression of the class IV CHS3 was only increased significantly
with anidulafungin (data not shown). Previously we showed that
the PKC, Ca2+-calcineurin and HOG pathways all regulated CHS
expression [31]. We then used reporter constructs to establish
Author Summary
Fungal pathogens are increasingly important agents of
human disease and are also difficult to treat since few
antifungal agents kill the invading organism. The cell wall
of a fungus is essential for its viability and this can be
attacked by a new generation of antifungal antibiotics
called echinocandins. Echinocandins such as caspofungin
are normally cidal for the human pathogen Candida
albicans. These inhibit the synthesis of b(1,3)-glucan, a
major strength-imparting polysaccharide in the cell wall.
Treatment of C. albicans with echinocandins in vitro
stimulated the formation of a second cell wall polysaccha-
ride—chitin, which rescued the cells. Treatments that
increased the chitin content of the C. albicans cell wall
reduced the efficacy of echinocandins and could even
induce the formation of novel structures such as a salvage
septum that enabled the cells to continue to undergo cell
division under otherwise lethal conditions. Combined
treatments with echinocandins and chitin synthase inhib-
itors synergized strongly, highlighting the potential for
potent combination therapies with enhanced fungicidal
activity.
Figure 1. Upregulation of CHS expression in response to
caspofungin is dependent on the PKC, HOG and Ca2+-
calcineurin pathways. Response of CHS promoter-lacZ reporters in
the absence (empty bars) and presence (solid bars) of caspofungin in
signal transduction mutants. Error bars are S.D. (n = 9 from three
separate experiments). Asterisks indicate significant differences
(p,0.05) compared to the untreated control in the same genetic
background. # indicates significantly different (p,0.05) to the wild
type cells in the same growth conditions. The fold inductions for LacZ
activity upon caspofungin exposure are shown in Table S2.
doi:10.1371/journal.ppat.1000040.g001
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which signalling pathways were required to activate these
transcriptional responses to echinocandins. The mutants tested
had the following genes deleted; HOG1 encoding the MAP kinase
of the HOG pathway, MKC1 encoding the MAP kinase of the
PKC pathway, and the calcineurin catalytic subunit CNA1.
Mutations in these pathways affected both the basal level of gene
expression and the response to caspofungin. Mutant strains with
deletions in the HOG pathway (hog1D) showed no increase in
expression of CHS1, CHS2 and CHS8 when caspofungin was
applied (Figure 1). Up-regulation of CHS1 was not seen in cna1D
mutants after caspofungin addition, therefore the Ca2+-calcineurin
pathway was involved in the regulation of CHS1. Equivalent
analyses showed that the PKC pathway contributed to the up-
regulation of the expression of CHS2 and CHS8 upon exposure to
caspofungin.
Caspofungin treatment of cells also led to a 2.5-fold increase in
specific chitin synthase activity measured in mixed membrane
preparations (Figure 2A), and a near 3-fold increase in the chitin
content of the cells (Figure 2B). The measured stimulation of chitin
synthase activity was dependent on the presence of two class I
enzymes Chs2p and Chs8p and on the Ca2+-calcineurin, PKC and
HOG pathways (Figure 2A). The total chitin content stimulated by
caspofungin was largely dependent on Chs3p and this also
required a functional PKC pathway and the presence of
calcineurin (Figure 2B). The HOG pathway also had a significant
influence on the stimulation of chitin content by caspofungin. The
effect of point mutations in FKS1 was also determined by
measuring cell wall chitin content (Figure 2B). Strain NR3, which
was resistant to caspofungin as a result of homozygous point
mutations in the b(1,3)-glucan synthase gene FKS1 [9] had an
almost three-fold increase in chitin content and lost the stimulation
of chitin synthesis by caspofungin (Figure 2B). We further
implicated the PKC pathway in the response to caspofungin by
showing phosphorylation of Mkc1p in wild type cells treated with
caspofungin (Figure 2C). We also quantified an increase in Chs3p
upon caspofungin treatment by western analysis using anti-GFP
antibodies and a strain engineered with a C-terminal YFP tag
fused to Chs3p [41] (Figure 2D). Therefore, the HOG, PKC and
Ca2+-calcineurin signalling pathways were found to mediate the
elevation of chitin synthase gene expression, chitin synthase
activity and chitin content in response to caspofungin.
Activation of cell wall salvage pathways protects against
echinocandin treatment
Having shown previously that Calcofluor White (CFW) and
Ca2+ are activators of the cell wall compensatory signalling
pathways that could stimulate chitin synthesis [31]; we determined
whether pre-treatment of cells with such agonists could protect
cells from the cidal affects of caspofungin. Inocula of wild type or
various mutant strains of C. albicans were grown in YPD, with and
without added CaCl2 and CFW, before washing, dilution and
plating onto agar containing caspofungin and other supplements
(Figure 3). The homozygous fks1 point mutant, strain NR3, which
was greatly reduced in sensitivity to caspofungin [9,14] was
included as a control. Under normal growth conditions, the cna1D,
mkc1D and chs3D mutants were hypersensitive to a low
concentration of caspofungin (0.032 mg/ml) compared to wild
type cells. The strains did not show significant sensitivity to
100 mg/ml CFW alone but CFW was found to act synergistically
with 0.032 mg/ml caspofungin to enhance killing (Figure 3). Only
the fks1 point mutant was able to grow at a higher caspofungin
concentration (16 mg/ml). Pre-treatment of the inoculum by
growth in CaCl2 and CFW (rows marked with asterisks)
significantly reduced the efficacy of 16 mg/ml caspofungin against
wild type cells and was dependent upon MKC1, HOG1, CNA1, and
CHS2, CHS3 and CHS8 (Figure 3). At lower caspofungin
concentrations less dependency on these genes was found. These
results suggest that stimulation of chitin synthesis accounted for
decreased caspofungin sensitivity and inhibition of chitin assembly
increased caspofungin toxicity. Combining FK506 with caspofun-
gin phenocopied the effects of the cna1D mutation (data not
shown). Experiments were also carried out using CaCl2 or CFW
pre-treatments alone. Priming cells with CaCl2 alone conferred
more caspofungin protection than treatment with CFW alone
(data not shown).
Pre-growing cells in CaCl2 and CFW supplemented medium
was also found to protect cells against caspofungin in liquid culture
on YPD or RPMI 1640. Using the CLSI method we determined
that pre-growing cells with CaCl2 and CFW significantly increased
the MIC for caspofungin by up to 6 doubling dilutions (Figure 4).
The MIC to anidulafungin and micafungin was also increased by
pre-treatment of wild type strains with CaCl2 and CFW however,
MIC to fluconazole, amphotericin B, terbinafine and 5-flucytosine
remained unchanged (data not shown).
Growth of S. cerevisiae on glucosamine–supplemented medium
has been shown to stimulate chitin synthesis [42]. Therefore, C.
albicans yeast cells were pre-grown on glucosamine-supplemented
YPD to establish whether this would also lead to protection against
caspofungin. Cells grown in YPD supplemented with 23 mM
glucosamine had an almost two-fold increase in chitin content
compared to the control cells (data not shown) and glucosamine-
grown cells were considerably less sensitive to caspofungin
(Figure 5). This protection did not require Chs3p, Cna1p and
Mkc1p. Therefore, this compensatory mechanism could occur
even in mutants with deletions in individual signalling pathways of
the cell wall compensatory response and in the absence of Chs3p -
the chitin synthase responsible for synthesizing the majority of
chitin in wild type cells.
Cells with elevated chitin content have reduced
sensitivity to caspofungin
Wild type cells were grown in media containing CaCl2 and
CFW, and then washed, diluted and plated onto YPD agar
containing 16 mg/ml caspofungin. Colonies emerged that con-
tained punctate rich zones of growth within a lawn of cells that
when re-grown were resistant to 16 mg/ml caspofungin (Figure 6A,
left panel). In contrast to the inoculum these resistant cells stained
brightly with CFW indicating higher chitin content (Figure 6B)
and they excluded the vital dye propidium iodide indicating they
were viable (Figure 6C). In contrast, sensitive cells surrounding
these rich zones of growth were susceptible to caspofungin, stained
poorly with CFW, and were propidium iodide-sensitive and non-
viable (Figure 6B and 6C). However, when inocula taken from
parts of the colony outside the rich zones of growth were plated
onto caspofungin-agar a few colonies arose which contained cells
that were caspofungin insensitive and of high chitin content
(Figure 6A, right panel). All colonies emerging on such plates could
be propagated indefinitely on caspofungin-containing agar. When
such cells were grown without caspofungin selection, they reverted
quickly to become caspofungin-sensitive, and the reverted cells
stained poorly with CFW (Figure 6D). Pre-treatment with CaCl2
and CFW stimulated the emergence of resistant colonies at a
higher rate than occurred when cells were pre-treated with sub-
MIC levels of caspofungin. For example, when cells were pre-
treated with CaCl2 and CFW the rate at which resistant colonies
emerged was approximately 1 in 120 cells. This compared to the
emergence of resistant colonies from approximately 1 in 1.36106
cells that were pre-treated with 0.032 mg/ml caspofungin.
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Figure 2. Activation of chitin synthesis by caspofungin. Chitin synthase activity (A) and chitin content (B) of various chitin synthase, signal
transduction and fks1 point mutants (fks1/FKS1=NR2; fks1/fks1=NR3) in the absence (empty bars) and presence (solid bars) of 0.032 mg/ml
caspofungin. Isolation of NR2 and NR3 are described in Douglas et al (1997) [9]. Asterisks indicate significant differences (p,0.05) compared to the
untreated control for each strain. # indicates a significant difference (p,0.05) to the wild type cells in the same growth conditions. Chitin synthase
assays were performed in triplicate (average6SD, n= 3). Cell wall chitin assays were performed five times on three biologically independent samples
(average 6SD, n = 15). Time course (min) of Mkc1 phosphorylation in wild type cells in response to 0.032 mg/ml caspofungin (C). Western analysis of
Chs3p levels in cells exposed to 0.032 mg/ml caspofungin, strain NGY477 carries Chs3p C-terminally tagged with YFP and BWP17 is the untagged
parental strain (Table S1) (D).
doi:10.1371/journal.ppat.1000040.g002
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The intensity of CFW fluorescence of yeast cells was found to be
an accurate reflection of the relative chitin content. Within a
population of cells the average chitin content was found to be
stimulated by treatment with CaCl2 + CFW or by sub-MIC
concentrations of caspofungin (Figure 6E). Cells that were pre-
treated with CaCl2 and CFW and then cultured in sub MIC
concentrations of caspofungin had the highest levels of chitin
(Figure 6E, and Figure S1). Thus exposure to CaCl2 and CFW and
to caspofungin led to both an increase in the average chitin
content of cells (Figure S1) and the selection of a sub-population of
caspofungin resistant cells that formed zones of rich growth within
colonies. When chitin-rich, caspofungin-insensitive cells were
transferred to fresh YPD medium lacking caspofungin their chitin
content declined to control unstimulated levels within 4–5 h
equivalent to approximately 3–4 generations (Figure 6F). Thus the
activation of chitin in response to caspofungin was a transient
adaptation and upon removal of the drug chitin content returned
to wild type levels.
Salvage chitin synthesis involves multiple CHS
isoenzymes and can generate a novel septum that
rescues cell division and viability
Having established that treatment with echinocandins leads to a
compensatory up-regulation of chitin synthesis, we next used a
panel of single and double chs mutants to determine which chitin
synthase enzymes were required to rescue the cells from the effects
of echinocandins. By measuring the pattern and relative amount of
CFW fluorescence we observed that Chs3p was responsible for
synthesising the majority of chitin induced by caspofungin
treatment (Figure 7 panels 1–16). Pre-growing the wild-type,
chs2Dchs8D, chs2D and chs8D mutants in CaCl2 and CFW (Figure 7
panels 17, 19, 21 & 24) led to an overall increase in cell wall chitin
content. Significant amounts of chitin accumulated at the poles of
the chs3D and chs2Dchs3D mutants when pre-grown in CaCl2 and
CFW (Figure 7 panels 20 & 23) suggesting that pre-treatment
stimulates the remaining chitin synthase enzymes to synthesize
salvage chitin in the absence of Chs3p. Likewise, the chs1D and
chs1Dchs3D mutants had concentrated areas of chitin at the septum
after pre-treatment with CaCl2 and CFW (Figure 7 panels 18 and
22). In all cases, pre-treatment and then exposure to caspofungin
stimulated production of salvage chitin (Figure 7 panels 25–32) via
activation of multiple Chs enzymes. Moreover, mutants lacking
Chs3p and Chs1p were able to survive in the presence or absence
of caspofungin when pre-grown in CaCl2 and CFW-containing
medium (Figure 7 panels 22 and 30). This is remarkable in view of
the fact that CHS1 is essential for C. albicans and that Chs3p has
been thus far been considered to be the key chitin synthase of the
cell wall salvage pathway in S. cerevisiae [7]. In this double mutant,
the cells grown in CaCl2 and CFW-containing medium had
unusually bright CFW-staining and thickened septa that formed
proximal to the normal location at the mother-bud neck region
(Figure 7 panel 22 and Figure 8A–C). These salvage septa also
stained with Wheat Germ Agglutinin (WGA)-Texas Red indicat-
ing that they were chitin rich (data not shown). Chs3p and Chs1p
normally collaborate to form the chitin ring and primary septal
plate of wild type septa respectively, but these salvage septa were
Figure 3. Pre-growing cells in CaCl2 and CFW reduces their susceptibility to caspofungin. Plate dilution sensitivity tests of wild type
(SC5314), a fks1 homozygous point mutant (NR3) and a range of signalling and chitin synthase single and double mutants on YPD agar containing
CFW, caspofungin or CFW and caspofungin. Rows marked with * indicate pre-growth of the inoculum in YPD containing both CaCl2 and CFW to raise
the chitin content of the cells. Cell numbers per spot are from 5000, 500, 50 to 5 cells, from left to right.
doi:10.1371/journal.ppat.1000040.g003
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formed in the absence of these two chitin synthases. The salvage
septum was able to restore the capability for cell division, so that
the formation of septum-less chains of cells and subsequent cell
lysis normally associated with the lack of Chs1p was abrogated and
viability was restored (Figure 8D, E and Figure 8F). Abrogation of
these phenotypes associated with the chs mutations was entirely
dependent upon chitin synthesis and could be inhibited completely
by treatment with nikkomycin Z (Figure 8F). In pre-treated wild
type cells or the fks1 point mutant, inhibition of chitin assembly by
CFW or chitin synthesis by nikkomycin Z was strongly synergistic
with caspofungin in killing cells even under conditions that
maximally induce cell wall compensatory mechanisms (Figure 9).
Treatment with RO-09-3143, a selective chitin synthase inhibitor
developed by Roche against the class II enzyme Chs1p [43],
phenocopied all the effects of the chs1 conditional mutation (data
not shown). These observations strongly support the conclusion
that the Chs2p and/or Chs8p class I chitin synthases are
responsible for synthesizing the chitin in the salvage septum that
rescues the cells under these conditions.
Discussion
The echinocandins are proving to be a safe and efficacious new
class of antifungal drug for the treatment of systemic mycoses
[11,44]. Laboratory-generated point mutations in the Fks1p target
around the 645Ser hotspot region alter the affinity for these non-
competitive inhibitors and results in reduced susceptibility [9,15].
However, there are a few recorded cases of failed echinocandin
therapy in the treatment of Candida infections caused by C. albicans
[45–48], C. glabrata [49], C. parapsilosis [50,51] and C. krusei [52]. In
two cases, the decreased echinocandin sensitivity of recovered C.
albicans isolates was shown to be due to mutations in FKS1 [47,48].
In addition, the emergence of a C. krusei isolate with decreased
caspofungin susceptibility [53] was found subsequently to have a
heterozygous mutation in the FKS1 hotspot region [17]. It has also
been suggested that an increase in cell wall chitin may explain the
so-called ‘‘paradoxical effect’’ whereby some clinical isolates exhibit
decreased sensitivity to increased concentrations of caspofungin
[54]. Collectively these observations suggest that the sensitivity of a
strain of Candida may relate in part to aspects of fungal physiology
other than the affinity of the Fks1p target protein for echinocandins.
We have shown by in vitro experiments that C. albicans can rapidly
respond to the presence of echinocandins by elevating chitin content,
and that this response protects the cells from cell wall damage due to
inhibition of b(1,3)-glucan synthesis. This may occur either by
selection of a sub-population of naturally occurring chitin-rich cells,
and/or by induction of the cell wall compensatory mechanisms that
activate chitin synthesis. Our data predict that elevation in chitin
content can offset the loss of cell wall integrity caused by echinocandin
treatment. Although no direct measurements of the mechanical
robustness of the cell wall have been devised in fungi, we show that
survival against high levels of echinocandins is chitin synthesis-
dependent and that the class I enzymes, Chs2p and Chs8p play vital
roles in this respect. All treatments and conditions that led to elevation
of chitin content also increased the MIC to echinocandins. It is also
formally possible that changes in the cell wall, other than induction o
chitin synthesis, also contribute to the changes in sensitivity to
caspofungin that we have observed.
As demonstrated previously [31], at least three signal transduc-
tion pathways participate in the compensatory responses - PKC,
Ca2+-calcineurin and HOG. Of these, the Ca2+-calcineurin
pathway plays a key role in activating class I chitin synthases that
are important for the compensatory response to caspofungin.
Caspofungin treatment activated these pathways and led to
increased transcription of CHS1, CHS2 and CHS8 and increased
levels of Chs3p in cells.
The class II enzyme of C. albicans, Chs1p, is normally essential
for viability and is responsible for synthesis of the primary septum
and for stabilizing lateral cell wall integrity [36]. As in S. cerevisiae,
the class IV enzyme Chs3p synthesizes the chitin ring around the
rim of the primary septal plate and makes 80–90% of the total cell
wall chitin of both yeast and hyphal cells [38,40]. Remarkably,
when pre-treated with CaCl2 and CFW, the conditional double
Figure 4. Pre-growing cells in CaCl2 and CFW increases their caspofungin MIC. The MIC of C. albicans strain SC5314 was measured in RPMI
1640 and YPD medium supplemented with caspofungin. The effect of growing the inoculum on YPD or YPD with CaCl2 and CFW was tested; cells
pre-grown in CaCl2 and CFW had an increased MIC for caspofungin.
doi:10.1371/journal.ppat.1000040.g004
Figure 5. Cells pre-grown in glucosamine have reduced
susceptibility to caspofungin. Pre-growing strains that were
hypersensitive to caspofungin (chs3D, cna1D, mkc1D) in YPD plus
23 mM glucosamine reduced their susceptibility to 0.032 mg/ml
caspofungin. Cell numbers per spot are from 5000, 500, 50 to 5 cells,
from left to right.
doi:10.1371/journal.ppat.1000040.g005
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chs1Dchs3D mutant grown under restrictive conditions for CHS1
expression was viable, had a normal morphology and was able to
construct a chitin-containing septum that enabled cell division. In
these cells, the only enzymes available for chitin synthesis were the
two class I enzymes, Chs2p and Chs8p, which thus far have not
been considered to be relevant for septum formation. Reinforcing
this, nikkomycin Z which is selectively active against class I chitin
synthases, prevented salvage septum synthesis and synergized
strongly with caspofungin in killing the fungal cells. C. albicans is
relatively insensitive to these inhibitors under normal conditions and
a class II (CaChs1p) inhibitor has been shown to be cidal in a genetic
background that lacks CaChs2p. We observed potent synergistic
effects when chitin assembly and synthesis, were inhibited, even
partially, by CFW and nikkomycin Z in the presence of b(1,3)-
glucan synthesis inhibitors. This underlines the potential for new
combination treatments, which inhibit both b(1,3)-glucan and chitin
synthesis. Cidal combinations of chemotherapeutic agents can also
be devised by using inhibitors of b(1,3)-glucan synthesis along with
agents that block the cell wall compensatory pathways of fungi [35].
These experiments point simultaneously to the remarkable
robustness and potential vulnerability of fungal cell wall biosynthesis
to chemotherapeutic intervention.
Materials and Methods
Strains, media and growth conditions
C. albicans strains used in this study are listed in Table S1 provided in
the Supporting Information section. C. albicans cultures were
Figure 6. Transient elevation of chitin in cells with reduced susceptibility to caspofungin. CaCl2 and CFW pre-treated cells grown on
medium containing 16 mg/ml caspofungin formed rich zones of growth within a lawn of surrounding cells (A, top panel). Inocula from the richer
zones of the colony contain resistant cells that grew well on 16 mg/ml caspofungin (A, left hand panel), while the surrounding cells grow poorly to
give few resistant colonies (A, right hand panel). DIC images and fluorescence micrographs of CFW and DAPI-stained cells (B, D) and propidium iodide
stained cells (C). In (B) cells from the 16 mg/ml caspofungin-resistant, richer zones of the colony have a higher chitin content, i.e. stain more strongly
with CFW, than caspofungin-sensitive cells and the inoculum. Caspofungin-sensitive cells are non-viable and take up propidium iodide whereas
caspofungin-insensitive cells are viable and do not (C). Increased CFW staining of resistant cells was lost upon sub-culture under non-selective
conditions, in the absence of caspofungin (D). The average relative chitin content of yeast cells, measured by intensity of CFW fluorescence, is shown
for cells in untreated controls and after pretreatment with 0.32 mg/ml caspofungin or CaCl2 and CFW and for cells pre-treated with CaCl2 and CFW
then grown in 0.32 mg/ml caspofungin (E). In (E) statistical differences are shown compared to untreated control (*P,0.001) and compared to Ca/
CFW pre-treated cultures (# P,0.001) (by t-test). Under-non-selective conditions, the relative chitin content of resistant cells decreased progressively
to that of the wild type (W.T.) as shown by the loss of CFW fluorescence (F). Error bars are S.D. (n = 6 from 3 separate experiments). Scale bars are
2 mm.
doi:10.1371/journal.ppat.1000040.g006
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maintained on solid YPD medium (1% (w/v) yeast extract, 2% (w/v)
mycological peptone, 2% (w/v) glucose, 2% (w/v) agar) and yeast cell
cultures were grown at 30uC inYPDwith shaking at 200 rpm.Hyphae
were induced by growing cells in RPMI-1640 at 37uC. The MRP1p-
CHS1/chs1D conditional mutant was maintained in medium contain-
ing maltose and grown in YPD to repress expression of CHS1 [36].
Figure 7. The role of chitin synthase isoenzymes in elevation of chitin levels in response to caspofungin. DIC (top panels) and
fluorescent images (bottom panels) of wild type and chsD mutant strains grown in the presence and absence of 0.032 mg/ml caspofungin with and
without pre-treatment of the inoculum with CaCl2 and CFW. Scale bars are 2 mm. Enlarged images are presented on the bottom panel showing the
chitin distribution in cells induced by CaCl2 and CFW in the chs3D (20) and chs1Dchs3D (22) mutants, with the latter showing induced synthesis of
salvage septa. In (23) increased chitin formation is shown as induced by CaCl2 and CFW and subsequent culture in caspofungin.
doi:10.1371/journal.ppat.1000040.g007
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Antifungal agents
Cells were grown in YPD supplemented with the following
antifungal agents: 0.032 mg/ml to 16 mg/ml caspofungin (Merck
Research Laboratories, New Jersey, USA) dissolved in sterile
water, 1.6 mg/ml cilofungin (Eli Lilly Laboratories, Indianapolis,
USA) dissolved in 100% ethanol, 0.3 mg/ml echinocandin B (Eli
Lilly Laboratories) dissolved in 50% (v/v) methanol, 10 mM
nikkomycin Z (Bayer, Chemical Co., Leverkusen, Germany)
dissolved in sterile water and 0.032 mg/ml anidulafungin (Pfizer,
Sandwich, Kent) dissolved in 100% DMSO. In some experiments
the inoculum was pre-treated by growing in YPD containing
0.2 M CaCl2 and 100 mg/ml CFW. Cultures were incubated at
30uC overnight with shaking at 200 rpm.
Caspofungin sensitivity testing
Caspofungin was incorporated into YPD plates at 0.032 mg/ml
and 16 mg/ml. In some experiments caspofungin was used in
combination with 100 mg/ml CFW (Sigma-Aldrich, UK). Yeast
cells were grown to late log phase in YPD and serially diluted to
generate suspensions containing 16106 to 1000 cells/ml in fresh
YPD. Plates were inoculated with 5 ml drops of each cell
suspension and incubated for 24 h at 30uC.
Antifungal susceptibility testing
Minimum inhibitory concentrations were determined by broth
micro-dilution testing using the CLSI (formerly NCCLS) guide-
lines M27-A2 [55]. Drug concentrations ranged from 2 ng/ml to
16 mg/ml for caspofungin, anidulafungin and micafungin,
0.032 mg/ml to 16 mg/ml for amphotericin B, terbinafine and
itraconazole and 0.13 mg/ml to 64 mg/ml for fluconazole and
flucytosine. Each drug was serially diluted with sterile water in flat
bottomed 96 well plates. Exponentially grown cultures were
diluted and 20 ml of a 16106 culture was inoculated in either
11 ml 26 RPMI-1640 or 26 YPD and 100 ml of culture was
added to each well. Plates were incubated for 24 h at 30uC for
YPD plates and 37uC for RPMI-1640 plates. After incubation
each well was mixed thoroughly and optical densities were read in
a VERSAmax tunable microplate reader (Molecular Devices,
California, USA) at 405 nm for RPMI-1640 plates and 600 nm
for YPD plates.
Measurement of CHS expression
Plasmid placpoly-6 was used for the lacZ promoter reporter
system [56] (Uhl and Johnson, 2001). A 1 kb upstream region from
the ATG start codon of each CHS1, CHS2, CHS3 and CHS8 ORF
was cloned into the PstI-XhoI sites of placpoly-6 generating
pCHS1plac, pCHS2plac, pCHS3plac, pCHS8plac respectively as
described previously [31]. C. albicans cultures were grown
overnight on YPD at then inoculated into fresh YPD medium
for 4 h, with or without echinocandins (0.032 mg/ml caspofungin
and the others at the concentrations stated above). Cells were
harvested after 4 h incubation, with shaking, at 30uC. Quantifi-
cation of b-galactosidase activity was determined using the method
previously described [31]. Specific b-galactosidase activities were
expressed as nmol o-nitrophenol produced min/mg/protein.
Statistical significant differences in the assay results were
determined with SPSS software using ANOVA and Post Hoc
Figure 8. The salvage septum of C. albicans in the chs1Dchs3D
double mutant (under repressing conditions for the condition-
alMRP1p-CHS1mutant). (A, B) The chained septum-less phenotype of
the chs1Dchs3D mutant (A) is abrogated by pre-growth on YPD with
CaCl2 and CFW to stimulate chitin synthesis prior to growth of the
mutant cells under repressing conditions (B,C). (C) Shows CFW-
fluorescence image of cells shown in (B). TEM images of proximal
offset thickened septa and (D,E). Scale bars are 2 mm for (A–D) and
0.2 mm for (E). Growth of the inoculum in YPD with CaCl2 and CFW
allows the chs1Dchs3D mutant to grow in the presence of caspofungin
while treatment of these cells with 10 mM nikkomycin Z leads to
inhibition of growth and cell lysis (F).
doi:10.1371/journal.ppat.1000040.g008
Figure 9. Synergistic inhibition of growth of a wild type strain
(SC5314) and an fks1 homozygous point mutant (NR3) by
16 mg/ml caspofungin and 100 mg/ml CFW or 10 mM nikkomy-
cin Z as chitin synthase inhibitors is further demonstrated in
plate sensitivity tests.
doi:10.1371/journal.ppat.1000040.g009
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Dunnett’s T-test, P,0.05. When the results displayed unequal
variance the Dunnett’s T3 test was applied.
Measurement of chitin synthase activity
Mixed membrane fractions (MMF) were prepared from
exponential phase yeast cells and their chitin synthase activities
were measured as described previously [31].
Measurement of cell wall chitin content
Cell walls were prepared from exponential C. albicans yeast
cultures grown in YPD and the chitin content was measured as
described previously [31].
Western analysis of Chs3p
Overnight cultures of yeast cells of NGY477 (Chs3p-YFP) and
BWP17 (untagged) were diluted 1:100 into 50 ml YPD supple-
mented with uridine and 0.032 mg/ml caspofungin and incubated
with shaking for 4 h at 30uC. BWP17 [57], the untagged parent
strain of NGY477, provided a negative control for the anti-GFP
antibody [41]. After treatment, cells were harvested by centrifu-
gation (1 5006g, 2 min, 4uC), washed in 1 ml cold Lysis Buffer
(50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.5% NP40, 2 mg/ml
Leupeptin, 2 mg/ml Pepstatin, 1 mM PMSF) and finally resus-
pended in 250 ml cold Lysis Buffer. Cells were broken using a
FastPrep machine and acid-washed glass beads. The extracts were
clarified by centrifugation (16 0006g, 5 min, 4uC). Protein
samples (15 mg each) were separated by SDS-polyacrylamide gel
electrophoresis (SDS-PAGE) using the XCell SureLockTM Mini-Cell
system with NuPAGEHNovex Bis-Tris 4-12% pre-cast gels in
NuPAGEH MOPS-SDS Running Buffer containing NuPAGEH
Antioxidant (Invitrogen Ltd, Paisley, UK) as per the manufactur-
er’s instructions. The proteins were transferred to InvitrolonTM
PVDF Membranes (Invitrogen) following the manufacturer’s
instructions. The membranes were then rinsed in PBS, blocked
in PBS-T+10% BSA (PBS, 0.1% Tween-20, 10% (w/v) BSA) for
30 min at RT and incubated overnight at 4uC in PBS-T+5% (w/
v) BSA (PBS, 0.1% Tween-20, 5% (w/v) BSA) containing a 1:2000
dilution of anti-GFP Antibody (Roche, Basel, Switzerland). The
membranes were washed five times for 5 min in PBS-T (PBS,
0.1% Tween-20) and then incubated for 1 h at RT in PBS-T+5%
(w/v) BSA containing a 1:4000 dilution of anti-mouse IgG, (Fab
specific) peroxidase conjugate Antibody (Sigma-Aldrich). The
membranes were washed three times for 5 min in PBS-T and the
signal was detected using LumiGLOTM Reagent and Peroxide
(Cell Signaling Technology, Massachusetts, USA) as per the
manufacturer’s instructions.
Western analysis of Mkc1p
Western blots were carried out as above with the following
modification; a 1:1000 dilution of Phospho-p44/42 Map Kinase
(Thr202/Tyr204) Antibody (Cell Signaling Technology) was used
as the primary antibody. The secondary antibody was Anti-rabbit
IgG, HRP-linked Antibody (Cell Signaling Technology) diluted
1:2000.
Fluorescence Microscopy
Samples were fixed in 10% (v/v) neutral buffered formalin
(Sigma-Aldrich) and examined by phase differential interference
contrast (DIC) microscopy. Cells were stained with 25 mg/ml
CFW to visualize chitin. Nuclei were stained by overlaying
samples with mounting media containing 1.5 mg/ml DAPI
(Vector Laboratories, Peterborough, UK). Cell membrane integ-
rity was determined by staining cells with 2 mg/ml propidium
iodide (Sigma-Aldrich). All samples were examined by DIC and
fluorescence microscopy using a Zeiss Axioplan 2 microscope.
Images were recorded digitally using the Openlab system (Open-
lab v 4.04, Improvision, Coventry, UK) using a Hamamatsu
C4742- 95 digital camera (Hamamatsu Photonics, Hamamatsu,
Japan). CFW fluorescence was quantified for individual yeast cells
using region of interest measurements. Mean fluorescence
intensities were then calculated for at least 35 individual cells. In
some experiments the exposure time for a series of fluorescence
images was fixed so the intensity of fluorescence relative to a
control of known chitin content was shown.
Electron Microscopy
Yeast cultures were harvested by centrifugation and the pellets
were fixed in 2.5% (v/v) glutaraldehyde in 0.1 M sodium
phosphate buffer (pH 7.3) for 24 h at 4uC. Samples were
encapsulated in 3% (w/v) low melting point agarose prior to
processing to Spurr resin following a 24 h schedule on a Lynx
tissue processor (secondary 1% OsO4 fixation, 1% Uranyl acetate
contrasting, ethanol dehydration and infiltration with acetone/
Spurr resin). Additional infiltration was provided under vacuum at
60uC before embedding in TAAB capsules and polymerising at
60uC for 48 h. 0.5 mm semi-thin survey sections were stained with
toluidine blue to identify areas of best cell density. Ultrathin
sections (60 nm) were prepared using a Diatome diamond knife on
a Leica UC6 ultramicrotome, and stained with uranyl acetate and
lead citrate for examination with a Philips CM10 transmission
microscope (FEI UK Ltd, Cambridge, UK) and imaging with a
Gatan Bioscan 792 (Gatan UK, Abingdon, UK).
Genes used in the study
Gene nomenclature is defined at the Candida genome database
(http://www.candidagenome.org/) and NCBI http://www.ncbi.
nlm.nih.gov/sites/entrez).
CHS1 (orf19.5188, XM_711849); CHS2 (orf19.7298,
XM_711340); CHS3 (orf19.4937, XM_712573); CHS8 (orf19.5384,
XM_712667); FKS1/GSC1 (orf19.2929, XM_716336); MKC1
(orf19.7523, X76708); HOG1 (orf19.895, XM_715923); CNA1
(orf19.6033).
Supporting Information
Figure S1 Population CFW fluorescence (chitin) heterogeneity
for wild type (WT) cells treated with 0.032 mg/ml caspofungin and
or 200 mM CaCl with 100 mg/m CFW (C&C). Cells were first
grown for 16 h in YPD in the absence of supplements, then grown
in YPD for 6 h at 30uC in the presence of caspofungin and, or
CaCl + CFW. The cells were then washed in water and stained
with 25 mg/ml CFW, and the relative fluorescence determined as
described in the Methods. The fluorescence of fifty cells per
treatment was then determined.
Found at: doi:10.1371/journal.ppat.1000040.s001 (0.69 MB
DOC)
Table S1 C. albicans strains used in this study
Found at: doi:10.1371/journal.ppat.1000040.s002 (0.15 MB
DOC)
Table S2 Fold induction of LacZ expression upon caspofungin
exposure
Found at: doi:10.1371/journal.ppat.1000040.s003 (0.04 MB
DOC)
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